Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Grines

Showing results (111-120 of 119) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 119 results.
The American Journal of Cardiology|November 13, 2001
Importance of time to reperfusion on outcomes with primary coronary angioplasty for acute myocardial infarction (results from the Stent Primary Angioplasty in Myocardial Infarction Trial)B R Brodie, G W Stone, M C Morice, et al.
Journal of the American College of Cardiology|January 13, 1998
Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot trial. Primary Angioplasty in Myocardial Infarction Stent Pilot Trial InvestigatorsG W Stone, B R Brodie, J J Griffin, et al.
Circulation|March 30, 1999
Clinical and angiographic follow-Up after primary stenting in acute myocardial infarction: the Primary Angioplasty in Myocardial Infarction (PAMI) stent pilot trialG W Stone, B R Brodie, J J Griffin, et al.
The New England Journal of Medicine|June 23, 2001
Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularizationE J Topol, D J Moliterno, H C Herrmann, et al.
The American Journal of Cardiology|November 13, 2001
Clinical pharmacology of higher dose eptifibatide in percutaneous coronary intervention (the PRIDE study)J E Tcheng, J D Talley, J C O'Shea, et al.
The American Journal of Cardiology|July 7, 1999
Low- versus high-dose recombinant urokinase for the treatment of chronic saphenous vein graft occlusionP S Teirstein, J T Mann, P E Cundey, et al.
Journal of the American College of Cardiology|June 1, 1997
A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. Second Primary Angioplasty in Myocardial Infarction (PAMI-II) Trial InvestigatorsG W Stone, D Marsalese, B R Brodie, et al.
Journal of the American College of Cardiology|April 30, 1998
Safety and cost-effectiveness of early discharge after primary angioplasty in low risk patients with acute myocardial infarction. PAMI-II Investigators. Primary Angioplasty in Myocardial InfarctionC L Grines, D L Marsalese, B Brodie, et al.
Circulation|December 24, 1997
Contemporary percutaneous treatment of unprotected left main coronary stenoses: initial results from a multicenter registry analysis 1994-1996S G Ellis, H Tamai, M Nobuyoshi, et al.
Pageof 12

Showing results (111-120 of 119) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
The American Journal of Cardiology|November 13, 2001
Importance of time to reperfusion on outcomes with primary coronary angioplasty for acute myocardial infarction (results from the Stent Primary Angioplasty in Myocardial Infarction Trial)B R Brodie, G W Stone, M C Morice, et al.
Journal of the American College of Cardiology|January 13, 1998
Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot trial. Primary Angioplasty in Myocardial Infarction Stent Pilot Trial InvestigatorsG W Stone, B R Brodie, J J Griffin, et al.
Circulation|March 30, 1999
Clinical and angiographic follow-Up after primary stenting in acute myocardial infarction: the Primary Angioplasty in Myocardial Infarction (PAMI) stent pilot trialG W Stone, B R Brodie, J J Griffin, et al.
The New England Journal of Medicine|June 23, 2001
Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularizationE J Topol, D J Moliterno, H C Herrmann, et al.
The American Journal of Cardiology|November 13, 2001
Clinical pharmacology of higher dose eptifibatide in percutaneous coronary intervention (the PRIDE study)J E Tcheng, J D Talley, J C O'Shea, et al.
The American Journal of Cardiology|July 7, 1999
Low- versus high-dose recombinant urokinase for the treatment of chronic saphenous vein graft occlusionP S Teirstein, J T Mann, P E Cundey, et al.
Journal of the American College of Cardiology|June 1, 1997
A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. Second Primary Angioplasty in Myocardial Infarction (PAMI-II) Trial InvestigatorsG W Stone, D Marsalese, B R Brodie, et al.
Journal of the American College of Cardiology|April 30, 1998
Safety and cost-effectiveness of early discharge after primary angioplasty in low risk patients with acute myocardial infarction. PAMI-II Investigators. Primary Angioplasty in Myocardial InfarctionC L Grines, D L Marsalese, B Brodie, et al.
Circulation|December 24, 1997
Contemporary percutaneous treatment of unprotected left main coronary stenoses: initial results from a multicenter registry analysis 1994-1996S G Ellis, H Tamai, M Nobuyoshi, et al.
Pageof 12